The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ranjan Jain
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter and Director Ranjan Jain sold 50,000 equity shares of Syschem India Ltd (BSE: 531173) through open market transactions between 19 February and 20 February 2026. The sale represents 0.11% of the total share capital and 0.09% on a diluted basis. Post-sale, Jain's holding stands at 27,90,000 shares, or 6.41% of paid-up capital (4.93% on diluted basis), down from 6.52% (5.02% diluted) prior to the transaction. The disclosure was filed under Regulation 29(2) of SEBI's SAST Regulations 2011, as Jain is part of the promoter group. The company's total equity capital is Rs 43.51 crore (4.35 crore shares of Rs 10 each).
The sale is very small in scale and unlikely to materially affect stock price or promoter control. However, retail investors should monitor if additional promoter sales follow, as a pattern of promoter selling can be a cautious signal.